Table of Contents
ISRN Microbiology
Volume 2012, Article ID 240841, 11 pages
http://dx.doi.org/10.5402/2012/240841
Research Article

Assessment of Some Inflammatory Biomarkers as Predictors of Outcome of Acute Respiratory Failure on Top of Chronic Obstructive Pulmonary Disease and Evaluation of the Role of Bacteria

Faculty of Medicine, Alexandria University, El-Kartoum Square, Alexandria 21526, Egypt

Received 25 February 2012; Accepted 18 April 2012

Academic Editors: B. Ayo and C. Baysse

Copyright © 2012 Hanaa Ahmed Shafiek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD), “Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease,” 2009, http://www.goldcopd.org/.
  2. “Death and DALY estimates by cause,” 2002, http://www.who.int/entity/healthinfo/statistics/bodgbddeathdalyestimates.xls.
  3. A. Di Stefano, G. Caramori, F. L. M. Ricciardolo, A. Capelli, I. M. Adcock, and C. F. Donner, “Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview,” Clinical and Experimental Allergy, vol. 34, no. 8, pp. 1156–1167, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Q. Gan, S. F. P. Man, A. Senthilselvan, and D. D. Sin, “Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis,” Thorax, vol. 59, no. 7, pp. 574–580, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. B. R. Celli and W. Macnee, “ATS/ERS Task ForceStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper,” European Respiratory Journal, vol. 23, pp. 932–946, 2004. View at Google Scholar
  6. P. M. A. Calverley, “Respiratory failure in chronic obstructive pulmonary disease,” European Respiratory Journal, Supplement, vol. 22, no. 47, pp. 26S–30S, 2003. View at Google Scholar · View at Scopus
  7. D. Lieberman, D. Lieberman, M. Ben-Yaakov et al., “Infectious etiologies in acute exacerbation of COPD,” Diagnostic Microbiology and Infectious Disease, vol. 40, no. 3, pp. 95–102, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Meloni, E. Paschetto, P. Mangiarotti et al., “Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations,” Journal of Chemotherapy, vol. 16, no. 1, pp. 70–76, 2004. View at Google Scholar · View at Scopus
  9. J. R. Hurst, W. R. Perera, T. M. A. Wilkinson, G. C. Donaldson, and J. A. Wedzicha, “Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 1, pp. 71–78, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. D. E. O'Donnell and C. M. Parker, “COPD exacerbations · 3: pathophysiology,” Thorax, vol. 61, no. 4, pp. 354–361, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. E. F. M. Wouters, K. H. Groenewegen, M. A. Dentener, and J. H. J. Vernooy, “Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations,” Proceedings of the American Thoracic Society, vol. 4, no. 8, pp. 626–634, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. L. G. Franciosi, C. P. Page, B. R. Celli et al., “Markers of exacerbation severity in chronic obstructive pulmonary disease,” Respiratory Research, vol. 7, article 74, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. S. M. Weiss and L. D. Hudson, “Outcome from respiratory failure,” Critical Care Clinics, vol. 10, no. 1, pp. 197–215, 1994. View at Google Scholar · View at Scopus
  14. D. A. Mahler and C. K. Wells, “Evaluation of clinical methods for rating dyspnea,” Chest, vol. 93, no. 3, pp. 580–586, 1988. View at Google Scholar · View at Scopus
  15. K. M. L. Bedewy, M. N. E. Elsayed, and M. I. Mahmoud, “Ventilator-associated pneumonia: serum TNF∞ and determination of the role of some atypical bacterial pathogens by PCR,” Egyptian Journal of Medical Microbiology, vol. 10, no. 1, pp. 27–42, 2001. View at Google Scholar
  16. K. M. L. Bedewy, Y. N. Ibrahim, and M. A. Abdelfattah, “Serum RANTES and TNF∞ levels in patients with acute coronary events: correlation with Chlamydia pneumoniaeinfection,” Egyptian Journal of Medical Microbiology, vol. 12, pp. 33–46, 2003. View at Google Scholar
  17. J. V. Lightowler, J. A. Wedzicha, M. W. Elliott, and F. S. F. Ram, “Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: cochrane systematic review and meta-analysis,” British Medical Journal, vol. 326, no. 7382, pp. 185–187, 2003. View at Google Scholar · View at Scopus
  18. S. Putinati, L. Ballerin, M. Piattella, G. L. Panella, and A. Potena, “Is it possible to predict the success of non-invasive positive pressure ventilation in acute respiratory failure due to COPD?” Respiratory Medicine, vol. 94, no. 10, pp. 997–1001, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Aburto, C. Esteban, F. J. Moraza, U. Aguirre, M. Egurrola, and A. Capelastegui, “COPD exacerbation: mortality prognosis factors in a respiratory care unit,” Archivos de Bronconeumologia, vol. 47, no. 2, pp. 79–84, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Brochard, J. Mancebo, M. Wysocki et al., “Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease,” New England Journal of Medicine, vol. 333, no. 13, pp. 817–822, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Kramer, T. J. Meyer, J. Meharg, R. D. Cece, and N. S. Hill, “Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure,” American Journal of Respiratory and Critical Care Medicine, vol. 151, no. 6, pp. 1799–1806, 1995. View at Google Scholar · View at Scopus
  22. T. Çelikel, M. Sungur, B. Ceyhan, and S. Karakurt, “Comparison of noninvasive positive pressure ventilation with standard medical therapy in hypercapnic acute respiratory failure,” Chest, vol. 114, no. 6, pp. 1636–1642, 1998. View at Google Scholar · View at Scopus
  23. N. Ambrosino, K. Foglio, F. Rubini, E. Clini, S. Nava, and M. Vitacca, “Non-invasive mechanical ventilation in acute respiratory failure due to chronic obstructive pulmonary disease: correlates for success,” Thorax, vol. 50, no. 7, pp. 755–757, 1995. View at Google Scholar · View at Scopus
  24. A. Carlucci, J. C. Richard, M. Wysocki, E. Lepage, and L. Brochard, “Noninvasive versus conventional mechanical ventilation: an epidemiologic survey,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 4, pp. 874–880, 2001. View at Google Scholar · View at Scopus
  25. G. W. Soo Hoo, S. Santiago, and A. J. Williams, “Nasal mechanical ventilation for hypercapnic respiratory failure in chronic obstructive pulmonary disease: determinants of success and failure,” Critical Care Medicine, vol. 22, no. 8, pp. 1253–1261, 1994. View at Google Scholar · View at Scopus
  26. P. K. Plant, J. L. Owen, and M. W. Elliott, “Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial,” The Lancet, vol. 355, no. 9219, pp. 1931–1935, 2000. View at Google Scholar · View at Scopus
  27. M. Confalonieri, G. Garuti, M. S. Cattaruzza et al., “A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation,” European Respiratory Journal, vol. 25, no. 2, pp. 348–355, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Moretti, C. Cilione, A. Marchioni, A. Tampieri, C. Fracchia, and S. Nava, “Incidence and causes of non-invasive mechanical ventilation failure after initial success,” Thorax, vol. 55, no. 10, pp. 819–825, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. N. F. Schlecht, K. Schwartzman, and J. Bourbeau, “Dyspnea as clinical indicator in patients with chronic obstructive pulmonary disease,” Chronic Respiratory Disease, vol. 2, no. 4, pp. 183–191, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Ferrer, M. Ioanas, F. Arancibia, M. A. Marco, J. P. De La Bellacasa, and A. Torres, “Microbial airway colonization is associated with noninvasive ventilation failure in exacerbation of chronic obstructive pulmonary disease,” Critical Care Medicine, vol. 33, no. 9, pp. 2003–2009, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. D. R. Baldwin and M. B. Allen, “Non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. Use it sooner than later to assist the “respiratory muscle pump",” British Medical Journal, vol. 314, pp. 163–164, 1997. View at Google Scholar
  32. G. Conti, M. Antonelli, P. Navalesi et al., “Noninvasive vs. conventional mechanical ventilation in patients with chronic obstructive pulmonary disease after failure of medical treatment in the ward: a randomized trial,” Intensive Care Medicine, vol. 28, no. 12, pp. 1701–1707, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Squadrone, P. Frigerio, C. Fogliati et al., “Noninvasive vs invasive ventilation in COPD patients with severe acute respiratory failure deemed to require ventilatory assistance,” Intensive Care Medicine, vol. 30, no. 7, pp. 1303–1310, 2004. View at Google Scholar · View at Scopus
  34. S. Baudouin, L. Turner, S. Blumenthal et al., “Non invasive ventilation in acute respiratory failure,” Thorax, vol. 57, no. 3, pp. 192–211, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Saetta, G. Turato, P. Maestrelli, C. E. Mapp, and L. M. Fabbri, “Cellular and structural bases of chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 6, pp. 1304–1309, 2001. View at Google Scholar · View at Scopus
  36. A. J. White, S. Gompertz, and R. A. Stockley, “Chronic obstructive pulmonary disease 6: the aetiology of exacerbations of chronic obstructive pulmonary disease,” Thorax, vol. 58, no. 1, pp. 73–80, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Saetta, S. Baraldo, and R. Zuin, “Neutrophil chemokines in severe exacerbations of chronic obstructive pulmonary disease: fatal chemo-attraction?” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 8, pp. 911–913, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Zhu, Y. S. Qiu, S. Majumdar et al., “Exacerbations of bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 1, pp. 109–116, 2001. View at Google Scholar · View at Scopus
  39. S. D. Aaron, J. B. Angel, M. Lunau et al., “Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 2, pp. 349–355, 2001. View at Google Scholar · View at Scopus
  40. A. Bhowmik, T. A. R. Seemungal, R. J. Sapsford, and J. A. Wedzicha, “Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations,” Thorax, vol. 55, no. 2, pp. 114–120, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Qiu, J. Zhu, V. Bandi et al., “Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 8, pp. 968–975, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Bathoorn, J. J. W. Liesker, D. S. Postma et al., “Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 4, no. 1, pp. 101–109, 2009. View at Google Scholar · View at Scopus
  43. P. Ball, “Epidemiology and treatment of chronic bronchitis and its exacerbations,” Chest, vol. 108, pp. 43S–52S, 1995. View at Google Scholar · View at Scopus
  44. R. Pela, “Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation,” Monaldi Archives for Chest Disease, vol. 53, no. 3, pp. 262–267, 1998. View at Google Scholar · View at Scopus
  45. M. Miravitlles, C. Espinosa, E. Fernández-Laso, J. A. Martos, J. A. Maldonado, and M. Gallego, “Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD,” Chest, vol. 116, no. 1, pp. 40–46, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Eller, A. Ede, T. Schaberg, M. S. Niederman, H. Mauch, and H. Lode, “Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function,” Chest, vol. 113, no. 6, pp. 1542–1548, 1998. View at Google Scholar · View at Scopus
  47. D. Bogaert, P. Van Der Valk, R. Ramdin et al., “Host-pathogen interaction during pneumococcal infection in patients with chronic obstructive pulmonary disease,” Infection and Immunity, vol. 72, no. 2, pp. 818–823, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. N. Soler, A. Torres, S. Ewig et al., “Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 5, pp. 1498–1505, 1998. View at Google Scholar · View at Scopus
  49. X. J. Li, Q. Li, L. Y. Si, and Q. Y. Yuan, “Bacteriological differences between COPD exacerbation and community-acquired pneumonia,” Respiratory Care, vol. 56, no. 11, pp. 1818–1824, 2011. View at Google Scholar
  50. S. H. Lin, P. H. Kuo, P. R. Hsueh, P. C. Yang, and S. H. Kuo, “Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa,” Respirology, vol. 12, no. 1, pp. 81–87, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. D. Lieberman, D. Lieberman, M. Ben-Yaakov et al., “Serological evidence of Mycoplasma pneumoniae infection in acute exacerbation of COPD,” Diagnostic Microbiology and Infectious Disease, vol. 44, no. 1, pp. 1–6, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. G. Papaetis, E. Anastasakou, T. Tselou et al., “Serological evidence of Mycoplasma pneumoniae infection in patients with acute exacerbation of COPD: analysis of 100 hospitalizations,” Advances in Medical Sciences, vol. 55, no. 2, pp. 235–241, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. F. Blasi, D. Legnani, V. M. Lombardo et al., “Chlamydia pneumoniae infection in acute exacerbations of COPD,” European Respiratory Journal, vol. 6, no. 1, pp. 19–22, 1993. View at Google Scholar · View at Scopus
  54. N. Miyashita, Y. Niki, M. Nakajima, H. Kawane, and T. Matsushima, “Chlamydia pneumoniae infection in patients with diffuse panbronchiolitis and COPD,” Chest, vol. 114, no. 4, pp. 969–971, 1998. View at Google Scholar · View at Scopus
  55. M. F. C. Beersma, K. Dirven, A. P. Van Dam, K. E. Templeton, E. C. J. Claas, and H. Goossens, “Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard",” Journal of Clinical Microbiology, vol. 43, no. 5, pp. 2277–2285, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. F. W. Arnold, J. T. Summersgill, A. S. Lajoie et al., “A worldwide perspective of atypical pathogens in community-acquired pneumonia,” American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 10, pp. 1086–1093, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. G. Lui, M. Ip, N. Lee et al., “Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia,” Respirology, vol. 14, no. 8, pp. 1098–1105, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. T. A. R. Seemungal, J. A. Wedzicha, P. K. MacCallum et al., “Chlamydia pneumoniae and COPD exacerbation,” Thorax, vol. 57, no. 12, pp. 1087–1089, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. F. Blasi, S. Damato, R. Cosentini et al., “Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment,” Thorax, vol. 57, no. 8, pp. 672–676, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. B. M. W. Diederen, P. D. L. P. M. van der Valk, J. A. W. J. Kluytmans, M. F. Peeters, and R. Hendrix, “The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease,” European Respiratory Journal, vol. 30, no. 2, pp. 240–244, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Varma-Basil, S. K. D. Dwivedi, K. Kumar et al., “Role of Mycoplasma pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease,” Journal of Medical Microbiology, vol. 58, no. 3, pp. 322–326, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. M. M. Ieven and V. Y. Hoymans, “Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence,” Journal of Clinical Microbiology, vol. 43, no. 1, pp. 19–24, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. B. Maraha, H. Berg, M. Kerver et al., “Is the perceived association between Chlamydia pneumoniae and vascular diseases biased by methodology?” Journal of Clinical Microbiology, vol. 42, no. 9, pp. 3937–3941, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. R. V. McCloskey, R. C. Straube, C. Sanders, S. M. Smith, and C. R. Smith, “Treatment of septic shock with human monoclonal antibody HA-1A: a randomized, double-blind, placebo-controlled trial,” Annals of Internal Medicine, vol. 121, no. 1, pp. 1–5, 1994. View at Google Scholar · View at Scopus
  65. M. Karin and Y. Ben-Neriah, “Phosphorylation meets ubiquitination: the control of NF-κB activity,” Annual Review of Immunology, vol. 18, pp. 621–663, 2000. View at Publisher · View at Google Scholar · View at Scopus
  66. M. J. May and S. Ghosh, “Signal transduction through NF-κB,” Immunology Today, vol. 19, no. 2, pp. 80–88, 1998. View at Publisher · View at Google Scholar · View at Scopus
  67. O. A. Khair, J. L. Devalia, M. M. Abdelaziz, R. J. Sapsford, H. Tarral, and R. J. Davies, “Effect of Haemophilus influenzae endotoxin on the synthesis of IL-6, IL-8, TNF-α and expression of ICAM-1 in cultured human bronchial epithelial cells,” European Respiratory Journal, vol. 7, no. 12, pp. 2109–2116, 1994. View at Publisher · View at Google Scholar · View at Scopus